You might also be interested in our Articles and White Papers page.
Creative Commons is devoted to expanding the range of creative works available to build upon legally and to share.
The Public Library of Science (PLoS) is a nonprofit open-access scientific publishing project. They created a library of journals and other scientific literature under an open content license.
Open Innovation Links
Lilly Open Innovation Drug Discovery. Connecting external investigators with Lilly science to find compounds that may become medicines.
Open Innovation Community. The Open Innovation Portal serves as an informational resource for thought leaders, consultants, authors, business leaders, academics and others who have a deep interest in open innovation.
InnoCentive, founded by Eli Lilly Company, is an open innovation and crowd sourcing pioneer using a proven Challenge Driven Innovation methodology to help organizations solve their key problems.
The Stop TB Partnership was established in 2001 building upon the Stop TB Initiative that was launched by WHO in 1998 and following a call at the Amsterdam Ministerial Conference in 2000. Its aim is to realize the goal of eliminating TB as a public health problem and, ultimately, to obtain a world free of TB.
The Critical Path to TB Drug Regimens (CPTR) Initiative is a broad collaboration of pharmaceutical companies; government, regulatory, and multilateral agencies; academia; civil society; advocates; and non-government organizations, that aims to accelerate the development of new, safe, and highly effective tuberculosis (TB) treatment regimens with shorter therapy durations.
The Global TB Alliance mission is to discover and develop better, faster-acting, and affordable drugs to fight tuberculosis.
The Lilly MDR-TB Partnership exists to save lives by preventing and treating multi-drug resistant tuberculosis (MDR-TB) - a terrible disease that afflicts millions of people in some of the poorest regions of the world.
The Lilly TB Drug Discovery Initiative is a not-for-profit public-private partnership with a mission to accelerate early-stage drug discovery by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries in search of new TB treatments.
XDRTB.org is an extraordinary effort to tell the story of extremely drug-resistant tuberculosis (XDR-TB) and TB through powerful photographs taken by James Nachtwey.